Rifampin‐induced acute kidney injury and hemolysis: A case report and literature review of a rare condition
journal contribution
submitted on 2025-05-19, 10:17 and posted on 2025-05-19, 10:19 authored by Fateen Ata, Hiba M. B. Magboul, Haneen A. A. Toba, Hadeel Alfar, Adel Al Bozom, Khaled Murshed, Muhammad ZahidRifampicin is a bactericidal drug used in various infectious diseases, including tuberculosis (TB). Nephrotoxicity is a rare side effect of intermittent Rifampin use and even less commonly continued use. We report a case of Rifampin‐induced acute tubular necrosis and hemolysis in a patient with latent TB with a relevant literature review.
Other Information
Published in: Clinical Case Reports
License: http://creativecommons.org/licenses/by/4.0/
See article on publisher's website: https://dx.doi.org/10.1002/ccr3.6780
Funding
Open Access funding provided by the Qatar National Library.
History
Language
- English
Publisher
WileyPublication Year
- 2022
License statement
This Item is licensed under the Creative Commons Attribution 4.0 International License.Institution affiliated with
- Hamad Medical Corporation
- Qatar University
- Qatar University Health - QU
- College of Medicine - QU HEALTH
- Weill Cornell Medicine - Qatar
